Topical Corticosteroids Market Forecast 2018 to 2024: Global Growth, Brands, Purchase Mode, Application, Medication Type, Potency Class, End User, Distribution Channel

According to a new report published by Data Bridge Market Research "Global Topical Corticosteroids Market Report 2017-2024", is expected to reach USD 4,440.4 million by 2024 from USD 2,828.4 million in 2016, at a CAGR of 5.8%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Free Sample Copy of this Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-corticosteroids-market

Key Topics Covered:

1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME
7. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS
8. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION
9. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE
10. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER
11. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL
12. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE
13. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS
14. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY
15. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE
16. COMPANY PROFILES
16.1. GLAXOSMITHKLINE PLC.
16.2. MERCK & CO. INC.
16.3. LEO PHARMA
16.4. ALMIRALL S.A.
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL
16.6. ZYLERA PHARMACEUTICALS
16.7. SANDOZ INTERNATIONAL GMBH
16.8. PFIZER INC.
16.9. SANOFI S.A.
16.10. ASTRAZENECA

Segmentation: Global Topical Corticosteroids Market

Global Topical Corticosteroids Market By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Brands (Betnovate, Betnovate N, Panderm Plus, Lobate, Cosvate G, Clop G, Tenovate GN, Lobate GM, Ultiderm, Flutivate, Fexin, Momate, Candiderm, Others), Purchase Mode (OTC-Based, Prescription-Based), Application (Acne, Dermatitis, Psoriasis, Skin Infections, Hyperpigmentation, Melasma, Others), Medication Type (Ointments, Creams, Liquid & Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Potency Class (Ultra High, High, Moderate, Mild), End User (Hospital, Dermatology Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) and Forecast to 2024.

Order a copy of Topical Corticosteroids Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-corticosteroids-market

Drivers: Global Topical Corticosteroids Market

The factors such as increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market.

INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION

There has also been gradual demographic transition from patterns of high fertility and mortality to low fertility and delayed mortality rates. As a result of such demographic transitions, the shape of global age distribution is changing. Increase in hypertension, temperature, etc. causes demand for vital sign monitoring devices. High blood pressure can lead to heart diseases, kidney diseases, and heart stroke and also cause death at times. According to the Centres for Disease Control and Prevention (CDC), about 70.0% of US adults of age 65 or older have high blood pressure and only 50% of them have it under control (less than 140/90 mmHg). Causing of several diseases like coronary artery disease, dementia, kidney failure, kidney artery aneurysm etc. affect older adults to disability, low quality of life, increase in health and long term care costs. According to HCUPnet, surgical treatment of lumbar/ lumbosacral degenerative disc disease has reached up to 105,195 till 2014 with a CAGR of 25.82% for the year 2004-2014 in U.S. According to an article published in National Center for Biotechnology Information (NCBI), surgeons nowadays for performing the procedures which were previously done as open surgery. Thus with the growing number of diseases, the demand for various drugs are also increasing.

GROWING NUMBER OF GERIATRIC POPULATION

Another major factor contributing to the growth of the topical corticosteroids market includes increasing number of the elderly population in the country. Furthermore, government support in the form of funding also drives the growth of this market.

According to the Population Reference Bureau (PRB) in 2016, in US, the ages 65 and older is estimated to grow double from 46 million to more than 98 million by 2060, and the 65-and-older age group’s contribution in the total population will rise to closely 24.0% from 15.0%. According to National Institute of Health (NIH), by 2050, the global life expectancy at birth is estimated to rise by almost eight years, ranging from 68.6 years in 2015 to 76.2 years in 2050.

The growing geriatric population leads to more number of spinal diseases as the elderly population gets affected very soon with the disease. For Instance, according to an article of National Center for Biotechnology Information (NCBI), almost 28.0% increase in anterior discectomy and fusion was detected in geriatric patients. According to World Population Ageing, the number of older people generally having age of 60 years or more is expected to increase from 841 million in 2013 to more than 2 billion in 2050.

GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS

The topical corticosteroids market is growing due to the growing market of the topical drug delivery globally. The drugs are of targeted type rather than systemic. The drugs are delivered to restricted sites, such as joints or diseased skin sites. The topical drugs are safe and more accurate in the delivery of drugs to newborns, the geriatric population, and people whose absorbing ability is conceded. The topical drug delivery is administered through non-oral routes for providing the complex and latest chemical entities. The deliveries of drugs are in a constant fashion and maintain active levels over extended time, without frequent oral applications.

INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT

The topical corticosteroids market is growing due to the increasing investment in research and development in the topical corticosteroids. The corticosteroids are the basic therapy for various inflammatory skin conditions. In last few years, the progression of original molecules with better and improved benefit/risk ratio and advanced formulations has increased the field of topical corticosteroid therapy.

According to an article published in National Center for Biotechnology Information (NCBI), the recent technologies which include swollen crosslinked silicone elastomer blend networks, amphiphilic resin linear polymers, sugar siloxanes and silicone hybrid pressure sensitive adhesives have been developed for better performance welfares and enhanced drug delivery efficacy.

NEW PRODUCT LAUNCHES BY KEY PLAYERS:

Topical corticosteroids are used for the treatment for atopic dermatitis since years. The hydrocortisone was the first corticosteroids to be used and now few additional corticosteroid compounds have been licensed for the treatment of atopic dermatitis. New and latest products have been launched for the growth of the market by various companies:
Teva launched the Desoximetasone Ointment, which is a topical steroid, used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Access Full Report: http://databridgemarketresearch.com/reports/global-topical-corticosteroids-market/

Major Players: Global Topical Corticosteroids Market

Some of the major players operating in this market are:-

Merck & Co. Inc.,
Pfizer Inc.,
Novartis AG,
Sanofi,
Actimis Pharmaceuticals,
LEO Pharma A/S,
Almirall,
S.A.,
Astra Zeneca,
Glaxosmithkline Plc,
Zylera Pharmaceuticals
among others.

Related Report

Global Biomarkers Market – Industry Trends and Forecast to 2024

Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cancer, Cardiovascular, Immunological), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-biomarkers-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.